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Introduction
The societal burden of seasonal influenza epidemics is quite heavy, with approximately 3-5 million cases and 250,000-500,000 estimated deaths worldwide every year [1] and a large economic impact, which includes both direct and indirect costs [2, 3] . Conventionally, attention has been directed toward influenza A, which accounts for the majority of influenza cases in most seasons [4] [5] [6] [7] . However, influenza B can account for a considerable proportion of total cases [8] . Since the 1980s, influenza B viruses have belonged to two antigenically distinct lineages, called the Victoria and Yamagata lineages [9] ; this has constituted a challenge for seasonal influenza vaccines, as only one influenza B strain is included in the trivalent vaccine. Studies in the United States have shown that the frequent influenza B vaccine mismatches of recent years have been associated both with substantial increases in cases, hospitalizations and deaths (up to 970,000 cases, with 8200 hospitalizations and 485 deaths annually, in the USA) [10] , and with high influenza-related medical costs and costs due to productivity loss [11] . Despite the important role of influenza B, much of the published scientific literature regarding the epidemiology of influenza has focused on influenza A, and we still have a relatively poor understanding of the global epidemiology and disease burden of influenza B. Several studies have reported on the burden of disease attributable to influenza B in a single season, or during consecutive seasons in a single country [12, 13] . In order to improve our understanding of the burden and epidemiology of influenza B, we reviewed the influenza B viruses circulating in Italy from 2000 to 2015.
Materials and methods
The National Influenza Sentinel Surveillance System In Italy, the Influenza Sentinel Surveillance System (IN-FLUNET) was implemented nationwide in the 1999-2000 season by the Influnet working group [12] . INFLUNET is based on the voluntary participation of an average of 830 (range 648-902) general practitioners (including paediatricians) per year, covering about 1.5-2% of the national population in all Italian regions. The system aims to monitor the incidence of influenza-like illness (ILI) and to determine the extent, timing and severity of seasonal epidemics. GPs are asked to report ILI cases (defined as acute onset of fever + respiratory symptoms + one of the following symptoms: headache, general discomfort, asthenia) weekly (from week 42 to week 17) using standardized forms. A(H1N1)pdm2009 among young and older adults, and A(H3N2) among the elderly. On average, the proportion of influenza B cases on the total of tested samples was 23% (range < 1-78%) (Fig. 2) . 
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Discussion
Our results on influenza B virus infections in Italy are timely, in view of the recent introduction of a tetravalent influenza vaccine containing influenza B viruses of both the Victoria and Yamagata lineages. Our study reveals that influenza B virus was the predominant overall cause of influenza in two of the 13 influenza seasons from 2000/01 through 2012/13. However, circulation of the B virus during the inter-pandemic season was always demonstrated. Similar patterns of influenza B virus circulation have been described in the US, Europe and Hong Kong [12] [13] . In Italy, the proportion of influenza B cases in the study period averaged 23% (range < 1-78%), a value similar to the European (23% (1-60%)) and US (24% (< 1-44%)) averages [14] . In our study, < 1% of all ILI cases are tested for influenza each season, and very few B viruses were antigenically and genetically characterized, thus reducing the opportunity to identify the co-circulation of the two lineages in Italy. [15] [16] [17] . Influenza is generally recognised as an important disease which causes high excess mortality among the elderly, although children have been shown to play an important role in its transmission [18] [19] . Unlike the influenza A(H3N2) virus, the B virus predominantly infects children and young adults and is generally recognised as a mild influenza virus [20] . Data on severe influenza B virus infections and mortality are limited. A large study conducted in the US reported that 25% of all influenza-related mortality could be attributed to influenza B virus [21] . This is higher than the percentage seen in the present study, in which influenza B in- [14] . Unfortunately, as very few B influenza viruses in Italy were genotyped, information on the antigenic characteristics of circulating B viruses was not available at the national level. Our study demonstrates that influenza B virus infections are associated with substantial morbidity and that influenza surveillance and interventions including vaccination and treatment are still suboptimal. Our findings have important public health implications. Incorporating viral and epidemiological data will help obtain more accurate estimates of influenza disease burden and result in a better selection of strategies for influenza prevention and control [25] .
